In vitro studies of 100 strains of meningococci: clinical implications.
D000328:Adult; D000667:Ampicillin / Q000494:pharmacology; D001789:Blood Group Antigens; D002512:Cephalothin / Q000494:pharmacology; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D009345:Neisseria meningitidis / Q000145:classification / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013411:Sulfadiazine / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use
D001789:Blood Group Antigens; D010406:Penicillins; D013449:Sulfonamides; D013411:Sulfadiazine; D000667:Ampicillin; D002512:Cephalothin; D012293:Rifampin